Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR

The inability of neutrophils to eradicate Pseudomonas aeruginosa within the cystic fibrosis (CF) airway eventually results in chronic infection by the bacteria in nearly 80 percent of patients. Phagocytic killing of P. aeruginosa by CF neutrophils is impaired due to decreased cystic fibrosis transmembrane conductance regulator (CFTR) function and virulence factors acquired by the bacteria. Recently, neutrophil extracellular traps (NETs), extracellular structures composed of neutrophil chromatin complexed with granule contents, were identified as an alternative mechanism of pathogen killing. The hypothesis that NET-mediated killing of P. aeruginosa is impaired in the context of the CF airway was tested. P. aeruginosa induced NET formation by neutrophils from healthy donors in a bacterial density dependent fashion. When maintained in suspension through continuous rotation, P. aeruginosa became physically associated with NETs. Under these conditions, NETs were the predominant mechanism of killing, across a wide range of bacterial densities. Peripheral blood neutrophils isolated from CF patients demonstrated no impairment in NET formation or function against P. aeruginosa. However, isogenic clinical isolates of P. aeruginosa obtained from CF patients early and later in the course of infection demonstrated an acquired capacity to withstand NET-mediated killing in 8 of 9 isolates tested. This resistance correlated with development of the mucoid phenotype, but was not a direct result of the excess alginate production that is characteristic of mucoidy. Together, these results demonstrate that neutrophils can kill P. aeruginosa via NETs, and in vitro this response is most effective under non-stationary conditions with a low ratio of bacteria to neutrophils. NET-mediated killing is independent of CFTR function or bacterial opsonization. Failure of this response in the context of the CF airway may occur, in part, due to an acquired resistance against NET-mediated killing by CF strains of P. aeruginosa.

[1]  N. McElvaney,et al.  The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell , 2011, Archivum Immunologiae et Therapiae Experimentalis.

[2]  N. Lanson,et al.  RNA interference against CFTR affects HL60-derived neutrophil microbicidal function. , 2010, Free radical biology & medicine.

[3]  C. Garlanda,et al.  The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps , 2007, The Journal of experimental medicine.

[4]  V. Wahn,et al.  Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. , 2011, Blood.

[5]  D. Zurakowski,et al.  Pulmonary Outcome in Cystic Fibrosis Is Influenced Primarily by Mucoid Pseudomonas aeruginosa Infection and Immune Status and Only Modestly by Genotype , 1999, Infection and Immunity.

[6]  K. Malcolm,et al.  Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy , 2009, Journal of medical microbiology.

[7]  A. O'donnell,et al.  Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. , 1998, Chest.

[8]  Ramy K. Aziz,et al.  DNase Expression Allows the Pathogen Group A Streptococcus to Escape Killing in Neutrophil Extracellular Traps , 2006, Current Biology.

[9]  R. Henry,et al.  Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[10]  V. Nizet,et al.  M1 Protein Allows Group A Streptococcal Survival in Phagocyte Extracellular Traps through Cathelicidin Inhibition , 2009, Journal of Innate Immunity.

[11]  C. Haslett,et al.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. , 1985, The American journal of pathology.

[12]  D. Cabral,et al.  Mucoid Pseudomonas aeruginosa Resists Nonopsonic Phagocytosis by Human Neutrophils and Macrophages , 1987, Pediatric Research.

[13]  A. Zychlinsky,et al.  Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms , 2006, Cellular microbiology.

[14]  J. P. Sy,et al.  A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. , 2001, The Journal of pediatrics.

[15]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.

[16]  M. Vasil,et al.  Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. , 1987, The Journal of infectious diseases.

[17]  P. Janmey,et al.  Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. , 1996, The American journal of pathology.

[18]  N. McElvaney,et al.  LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline1 , 2009, The Journal of Immunology.

[19]  Eric Haugen,et al.  Comprehensive transposon mutant library of Pseudomonas aeruginosa , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Rubin Mucus structure and properties in cystic fibrosis. , 2007, Paediatric respiratory reviews.

[21]  R. Parad,et al.  Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. , 2004, Pediatrics.

[22]  J. Goff,et al.  Neutrophil extracellular trap formation by bovine neutrophils is not inhibited by milk. , 2006, Veterinary immunology and immunopathology.

[23]  V. Valentine,et al.  CFTR‐mediated halide transport in phagosomes of human neutrophils , 2010, Journal of leukocyte biology.

[24]  David A. D'Argenio,et al.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. P. Speert,et al.  Genetic Adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients Is Catalyzed by Hypermutation , 2008, Journal of bacteriology.

[26]  D. Foster,et al.  Seminal DNase Frees Spermatozoa Entangled in Neutrophil Extracellular Traps , 2005, Biology of reproduction.

[27]  M. Kosorok,et al.  Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition , 2001, Pediatric pulmonology.

[28]  Kristian Fog Nielsen,et al.  Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. , 2010, Environmental microbiology.

[29]  F. Conceição-Silva,et al.  Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps , 2009, Proceedings of the National Academy of Sciences.

[30]  M. Elkins,et al.  Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm Conditions , 2005, Journal of Clinical Microbiology.

[31]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.

[32]  C. Nast,et al.  Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa , 1991, Infection and immunity.

[33]  Á. Zorreguieta,et al.  Extracellular DNA: A Major Proinflammatory Component of Pseudomonas aeruginosa Biofilms , 2010, The Journal of Immunology.

[34]  J. Zieleński,et al.  Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. , 2005, The Journal of pediatrics.

[35]  K. Malcolm,et al.  Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils , 2005, Infection and Immunity.

[36]  R. Smith,et al.  Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes. , 1981, The Journal of laboratory and clinical medicine.

[37]  V. Nizet,et al.  Fetal calf serum contains heat-stable nucleases that degrade neutrophil extracellular traps. , 2009, Blood.

[38]  J. Carlin,et al.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. , 2001, The Journal of pediatrics.

[39]  P. Davis,et al.  State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? , 2003, Respiratory research.

[40]  L. Herzenberg,et al.  Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs , 2009, Proceedings of the National Academy of Sciences.

[41]  George M. Hilliard,et al.  Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. , 2002, Advanced drug delivery reviews.

[42]  C. Mellis,et al.  Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis , 1992, Pediatric pulmonology.

[43]  B. Holloway Genetic recombination in Pseudomonas aeruginosa. , 1955, Journal of general microbiology.

[44]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[45]  J. Warner,et al.  Desensitisation of neutrophil responses by systemic interleukin 8 in cystic fibrosis. , 1994, Thorax.

[46]  Arturo Zychlinsky,et al.  An Endonuclease Allows Streptococcus pneumoniae to Escape from Neutrophil Extracellular Traps , 2006, Current Biology.

[47]  V. Valentine,et al.  CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. , 2006, Biochemistry.

[48]  V. Deretic,et al.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.

[49]  M. Hallett,et al.  Reduced iC3b‐mediated phagocytotic capacity of pulmonary neutrophils in cystic fibrosis , 2005, Clinical and experimental immunology.

[50]  Adeline R. Whitney,et al.  Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Miller,et al.  Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. , 1999, Science.

[52]  A. Cowburn,et al.  Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation , 2009, European Respiratory Journal.

[53]  R. Dummer,et al.  Induction of Genes Mediating Interferon-dependent Extracellular Trap Formation during Neutrophil Differentiation* , 2004, Journal of Biological Chemistry.

[54]  G. Lenoir,et al.  In Cystic Fibrosis Homozygotes and Heterozygotes, Neutrophil Apoptosis Is Delayed and Modulated by Diamide or Roscovitine: Evidence for an Innate Neutrophil Disturbance , 2010, Journal of Innate Immunity.

[55]  N. Høiby,et al.  Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis , 1997, Pediatric pulmonology.

[56]  V. Valentine,et al.  The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils , 2008, Journal of leukocyte biology.

[57]  M. Vasil,et al.  Recombinant DNA approaches to the study of the regulation of virulence factors and epidemiology of Pseudomonas aeruginosa. , 1987, Antibiotics and chemotherapy.

[58]  S. Normark,et al.  Capsule and d‐alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps , 2007, Cellular microbiology.

[59]  A. Jesaitis,et al.  Compromised Host Defense on Pseudomonas aeruginosa Biofilms: Characterization of Neutrophil and Biofilm Interactions 1 , 2003, The Journal of Immunology.

[60]  Charles A. Johnson,et al.  Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. , 2007, The Journal of pediatrics.

[61]  P. Sly,et al.  Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. , 2009, The Journal of pediatrics.

[62]  L. Holmberg,et al.  Predictors of deterioration of lung function in cystic fibrosis * , 2002, Pediatric pulmonology.

[63]  C. Lowell,et al.  Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection. , 2009, Blood.

[64]  A. Oliver,et al.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.

[65]  J. Emerson,et al.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.

[66]  Stephen R. Clark,et al.  Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.

[67]  S. Grinstein,et al.  Abnormalities in the pulmonary innate immune system in cystic fibrosis. , 2006, American journal of respiratory cell and molecular biology.

[68]  R. van Furth,et al.  Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. , 1979, Immunology.

[69]  L. Herzenberg,et al.  Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways , 2008, Proceedings of the National Academy of Sciences.

[70]  Abdul Hakkim,et al.  Restoration of NET formation by gene therapy in CGD controls aspergillosis. , 2009, Blood.

[71]  J. Cavaillon,et al.  Neutrophils in Cystic Fibrosis Display a Distinct Gene Expression Pattern , 2008, Molecular medicine.

[72]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[73]  A. Pollard,et al.  Two distinct receptors mediate nonopsonic phagocytosis of different strains of Pseudomonas aeruginosa. , 2001, The Journal of infectious diseases.

[74]  G L Johnson,et al.  Tumor necrosis factor-alpha activation of the c-Jun N-terminal kinase pathway in human neutrophils. Integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis. , 2001, The Journal of biological chemistry.

[75]  H. Simon,et al.  Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps , 2009, Cell Death and Differentiation.

[76]  H. Fuchs,et al.  Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. , 1994, The New England journal of medicine.

[77]  Abdul Hakkim,et al.  Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps , 2010, The Journal of cell biology.

[78]  S. Lewenza,et al.  Pseudomonas aeruginosa produces an extracellular deoxyribonuclease that is required for utilization of DNA as a nutrient source. , 2010, Environmental microbiology.

[79]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[80]  J. G. Hirsch BACTERICIDAL ACTION OF HISTONE , 1958, The Journal of experimental medicine.

[81]  Richard C Boucher,et al.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.

[82]  M. Surette,et al.  A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus aureus , 2010, The Journal of Immunology.

[83]  Gerald B. Pier,et al.  Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.